🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

PRECIOUS-Gold rebounds as dollar eases; virus treatment hopes cap gains

Published 24/08/2020, 08:29 pm
© Reuters.
XAU/USD
-
XAG/USD
-
DX
-
GC
-
SI
-
PA
-
PL
-
DXY
-

* Global equities gain for second session

* Investors eye Fed Chair's address at Jackson Hole

* Interactive graphic tracking global spread of coronavirus: open https://tmsnrt.rs/3aIRuz7 in an external browser (Updates prices)

By Diptendu Lahiri

Aug 24 (Reuters) - Gold prices rose on Monday as the dollar dipped, making bullion cheaper for holders of other currencies, but hopes for progress in the treatment of COVID-19 limited gains in the safe-haven metal.

Spot gold XAU= was up 0.4% at $1,946.89 an ounce by 1240 GMT, having jumped 1% to $1,961.40 an ounce after early losses.

U.S. gold futures GCv1 gained 0.8% to $1,961.80.

"The dollar is softer today and, if we look at the larger picture, the world economy is still trying to recover from the effects of coronavirus," said Saxo Bank analyst Ole Hansen.

"Along with that, the risk of inflation continues to attract investors to gold."

The dollar index .DXY was down 0.4% after climbing to a more than one-week high in the previous session.

Investors are awaiting U.S. Federal Reserve Chairman Jerome Powell's address to the bank's annual symposium in Jackson Hole, Wyoming, on Thursday for signs of how aggressively it will seek to handle the long-term recovery from the pandemic. U.S. central bank should reiterate its pledge for ultra-low rates, providing some support for gold," Avtar Sandu, a senior commodities manager at Phillip Futures, said in a note.

"(It) may be expected to signal greater tolerance for above-target inflation, keeping real interest rates low."

Lower U.S. interest rates cut the opportunity cost of holding non-yielding bullion.

Central banks worldwide have rolled out massive stimulus measures to alleviate the economic damage caused by the COVID-19 pandemic, but that has also increased the probability of rising inflation.

Restricting gold's advance, equity markets gained for a second straight session after the U.S. Food & Drug Administration authorised the use of blood plasma from patients who have recovered from COVID-19 as a treatment for the disease. MKTS/GLOB

Silver XAG= rose 0.8% to $26.90 an ounce, platinum XPT= was up 0.6% at $924.29 and palladium XPD= eased 0.1% to $2,180.18.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.